ahlam1399
08-20-2015, 08:42 AM
Samsung Bioepis hires banks for planned Nasdaq IPO -source
SEOUL, Aug 20 (Reuters) - South Korea's Samsung Bioepis Co Ltd, a biosimilar drug development arm of conglomerate Samsung Group, has hired four banks to manage its planned U.S. listing next year, a...http://feeds.feedburner.com/~ff/reuters/mergersNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/mergersNews?a=BI5AUcU5OYY:pFemems6w0Q:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=BI5AUcU5OYY:pFemems6w0Q:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/mergersNews?a=BI5AUcU5OYY:pFemems6w0Q:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=BI5AUcU5OYY:pFemems6w0Q:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/mergersNews?a=BI5AUcU5OYY:pFemems6w0Q:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/mergersNews/~4/BI5AUcU5OYY
SEOUL, Aug 20 (Reuters) - South Korea's Samsung Bioepis Co Ltd, a biosimilar drug development arm of conglomerate Samsung Group, has hired four banks to manage its planned U.S. listing next year, a...http://feeds.feedburner.com/~ff/reuters/mergersNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/mergersNews?a=BI5AUcU5OYY:pFemems6w0Q:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=BI5AUcU5OYY:pFemems6w0Q:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/mergersNews?a=BI5AUcU5OYY:pFemems6w0Q:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=BI5AUcU5OYY:pFemems6w0Q:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/mergersNews?a=BI5AUcU5OYY:pFemems6w0Q:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/mergersNews/~4/BI5AUcU5OYY